foxo4-dri senolytic 2024 study

foxo4-dri senolytic 2024 study Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri senolytic 2024 study Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment FOXO4-DRI: Human Trial Status, Cancer
Brand: www.fysioparkdokkum.nl
SKU: 79721820039
Price: 27.65 USD
Availability: InStock
Rating: 4.3609 (24 reviews)

SKU: 79721820039

4.4

USD27.65 USD66.65

Pay in 4 interest-free payments of $6.91 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 7 - Sep 12

Description

The solubilized complex in the elution was immobilized by 2 h batch binding to M1 anti-Flag affinity resin at room temperature

Our products are crafted for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use